Alvotech and Teva Announce Filing Acceptance of U.S. Biologics License Applications for AVT05, a Proposed Biosimilar to Simponi® and Simponi Aria® (golimumab)
Notified -
Globe Newswire27-01-2025, 18:00
At the Yacht Club de Monaco the inauguration ceremony of the first Explorer Dock 21-03-2024, 23:26